European Companies Search Engine
UK funding (£118,927): Targeting cancer cells with CD95R-coated nanoparticles Ukri1 Oct 2014 UK Research and Innovation, United Kingdom
Overview
Text
Targeting cancer cells with CD95R-coated nanoparticles
| Abstract | Doctoral Training Partnerships: a range of postgraduate training is funded by the Research Councils. For information on current funding routes, see the common terminology at https://www.ukri.org/apply-for-funding/how-we-fund-studentships/. Training grants may be to one organisation or to a consortia of research organisations. This portal will show the lead organisation only. |
| Category | Training Grant |
| Reference | MR/L020440/1 |
| Status | Closed |
| Funded period start | 01/10/2014 |
| Funded period end | 30/09/2018 |
| Funded value | £118,927.00 |
| Source | https://gtr.ukri.org/projects?ref=MR%2FL020440%2F1 |
Participating Organisations
| Queen Mary University of London |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Queen Mary University of London, London.
The visualizations for "Queen Mary University of London - UK funding (£118,927): Targeting cancer cells with CD95R-coated nanoparticles"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
